AzTrials
AzTrials

AmputationNCT07915700

Hand Prosthesis Usability and Performance

A study testing Prototype hand prosthesis and Baseline Comparator Device in people with Amputation, run by Össur Iceland ehf at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study asks individuals with upper limb absence to use a new hand prosthesis, and compare it's performance to their own hand prosthesis Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Amputation
What is being tested?
Prototype hand prosthesis and Baseline Comparator Device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
9 Mar 2026to 1 Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Multi-articulating hand experience
  • At least 18 years old
  • Transradial, acquired amputation or congenital upper limb absence
  • Unilateral upper limb absence preferred Good socket comfort in own prosthesis (>/= 6 on Hanspal socket comfort score)

Who cannot join

  • Any health conditions that pose a risk to participation in study events (in the opinion of the Investigator), e.g. Visual impairment; Cognitive impairment
  • Cognitively unable to provide informed consent or comply with the study procedures

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Daire McGuinness contact

01506533178

dmcguinness@ossur.com

United States1 site, 1 recruiting
  • Ossur Americas

    Dublin, Ohio, 43017

    Lynsay Emmrich, +16149278008, lynsay.emmrich@emblamedical.com

    Recruiting

Other trials in United States

About this study

Official title: Validation of a Multi-articulating Hand Prosthesis

This study asks individuals with upper limb absence to use a new hand prosthesis, and compare it's performance to their own hand prosthesis

Read the detailed description

A multi-articulating hand prosthesis is compared within subject to baseline (own device) in terms of patient reported outcome measures of satisfaction and adoption, and functional performance

Conditions
Amputation
Being tested
Prototype hand prosthesis, Baseline Comparator Device

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prototype hand prosthesisDevice

    Prototype hand prosthesis

  • Baseline Comparator DeviceDevice

    All participants will use their own prosthesis

Study groups in NCT07915700
Study groupRoleWhat they receive
All participantsExperimentalAll participants will use the prototype device
Receives: Device: Prototype hand prosthesis; Device: Baseline Comparator Device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Grip Accuracy

    Functional observer rated test of ability to perform grips. This test assesses the feasibility that the device can be used as a reliable hand prosthesis when operated by the intended use population. An observer rates the successful achievement of the prompted outcome on a 0-3 scale (0= no output, 3= output achieved without error). The four grips (hand open, hand close, thumb rotation to palm, thumb rotation away from palm) are repeated x3, resulting in a minimum summary score of 0 or a maximum summary score of 36.

    Measured: At baseline and each post-treatment visit (x3 visits over 12 weeks)

Secondary outcomes (1)
  1. Disability of the Arm Shoulder and Hand

    The Disability of the Arm Shoulder and Hand (DASH) is a patient reported outcome measure assessing perceived personal ability. The questionnaire consists of 30 items which the participant scores on a 1-5 scale to indicate their perceived ability (1= no difficuly, 5=unable). The summary DASH DISABILITY/SYMPTOM SCORE = [(sum of n responses) - 1] x 25, where n is equal to the number of completed responses, and a maximum score of 100 can be achieved. A higher score indicates greater perceived disability.

    Measured: At baseline and each post-treatment visit (x3 visits over 12 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2026
  2. Study start9 Mar 2026
  3. Primary completion1 Mar 2028 (estimated)
  4. Study completion1 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07915700
Sponsor's protocol ID
CIP2022041968
Status last verified
Nov 2026
First submitted
28 Oct 2026
Last updated
4 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Prototype hand prosthesis and Baseline Comparator Device in people with Amputation, run by Össur Iceland ehf at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Daire McGuinness (01506533178, dmcguinness@ossur.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Grip Accuracy (time frame: At baseline and each post-treatment visit (x3 visits over 12 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in